Notify the patient of which MOUNJARO presentation they will be receiving and ensure training is appropriate for the specific MOUNJARO presentation
A 40-week trial supported by Eli Lilly showed that 5 mg, 10 mg, or 15 mg of tirzepatide lowered HbA1c levels by 2.01%, 2.24%, and 2.30% respectively, and the recommended 1 mg of Ozempic lowered HbA1c by 1.9%, demonstrating better results when using Mounjaro
The liquid needs to stay in contact with the sublingual tissue for as long as possible
And our overview of peptide pricing compares costs across different therapy categories
In individuals with type 2 diabetes and a heightened risk of cardiovascular events, tirzepatide demonstrated greater and clinically significant reduction in HbA1c compared to glargine at week 52
Summary: Retatrutide does not work equally for everyone whilst clinical trial results are promising, individual responses vary based on biology, lifestyle adherence, tolerability, and dose achieved